Jiangbo Pharmaceuticals Enterprises, Inc.

Jiangbo Pharmaceuticals Enterprises, Inc. is a U.S. drug company that manufactures and distributes sophisticated chemical and herbal drugs throughout the People's Republic of China.

-Portfolio of sophisticated drugs

-Strong revenue and profitability growth

-Collaborative research and development agreements with educational institutions

-Drug pipeline includes Chinese Class 1 and widely marketed OTC drugs

-Emphasis on branding and extensive distribution

Jiangbo Pharmaceuticals Enterprises, Inc., known in China as Laiyang Jiangbo Pharmaceuticals ("LJPC"), was established in July 2003 and is a medium-sized pharmaceutical company, currently producing and selling five Government approved drugs with several in the pipeline awaiting final approval. The company is located in Northeast China in an Economic Development Zone, Laiyang City , Shandong Province. 　　

Jiangbo has 440 full time sales representatives and 620 part time representatives located in all major commerce areas across China. The company has numerous GMP (Chinese State Drug Administration or the SDA) approved manufacturing facilities and production lines and is approved to produce tablets, capsules and granules. In 2007, Genesis produced 5 billion tablets, 50 million bags of granules and 50 million capsules. The Company's top five products include Clarithromycin sustained-release tablets, Itopride Hydrochloride granules, Ciprofloxacin Hydrochloride tablets, Paracetamol tablets and Baobaole Chewable Tablets.